XML 35 R21.htm IDEA: XBRL DOCUMENT v3.24.3
OTHER EXPENSE, NET
 9 Months Ended
Sep. 30, 2024
Other Income and Expenses [Abstract]  
OTHER EXPENSE, NET OTHER EXPENSE, NET
Other expense, net consists of:
Three Months Ended September 30,Nine Months Ended September 30,
(in millions)2024202320242023
Litigation and other matters$188 $24 $215 $(55)
Acquisition-related contingent consideration25 26 19 40 
Gain on sale of assets, net(5)(5)(10)(4)
Acquired in-process research and development costs15 — 18 — 
Acquisition-related transaction costs2 15 3 18 
Other, net— — — 1 
$225 $60 $245 $— 
For the three and nine months ended September 30, 2024, Litigation and other matters primarily relates to adjustments to provisions for certain legal matters. For the nine months ended September 30, 2023, Litigation and other matters primarily related to insurance recoveries regarding certain litigation matters.
Acquisition-related contingent consideration for the nine months ended September 30, 2024 and 2023 reflects changes in estimates in the timing and amounts of expected future royalty and milestone payments and in 2024 includes other adjustments of $18 million related to certain branded products.
Acquired in-process research and development costs for the three and nine months ended September 30, 2024 are related to certain Bausch + Lomb acquisitions.
Acquisition-related transaction costs for the nine months ended September 30, 2023 were primarily related to transaction costs incurred in connection with Bausch + Lomb’s acquisitions of XIIDRA® and the Blink® Product line.